Registered Office:
208 Okhla Industrial Estate,Phase-III,
New Delhi - 110020,
New Delhi, India.
Phone : 91-11-47476600
Fax : NA
Initial public offering of 40,058,844 equity shares of face value of Re. 1 each ("Equity Shares") of Mankind Pharma Limited ("The Company" or the "Issuer") for cash at a price of (Rs) 1,080 per equity share ("Offer Price") aggregating to (Rs) 4326.36 crores, comprising an offer for sale of 3,705,443 equity shares aggregating to (Rs) 400.18 crores by Ramesh Juneja, 3,505,149 equity shares aggregating to (Rs) 378.56 crores by Rajeev Juneja, 2,804,119 equity shares aggregating to (Rs) 302.85 crores by Sheetal Arora (collectively, the "Promoter Selling Shareholders"), 17,405,559 equity shares aggregating to (Rs) 1879.80 crores by Cairnhill Cipef Limited, 2,623,863 equity shares aggregating to (Rs) 283.38 crores by Cairnhill CGPE Limited, 9,964,711 equity shares aggregating to (Rs) 1076.19 crores by Beige Limited and 50,000 equity shares aggregating to (Rs) 5.40 crores by Link Investment Trust (collectively, the "Investor Selling Shareholders") (the "Promoter Selling Shareholders" and the "Investor Selling Shareholders", together, the "Selling Shareholders") (the "Offer for Sale" or the "Offer"). The offer shall constitute 10% of the post-offer paid-up equity share capital of the company.
Opens On
Closes On
Application
Allotment
25-Apr-23
27-Apr-23
1080.00-0.00
0.00-0.00
Minimum Application for shares in Nos :
13
Further Multiples of :
13
(Rs.Cr)
Lead Managers to the Issue
Project Cost
0.00
Axis Capital Ltd
Project Financed through Current Offer
4326.36
Post Issue Equity Share Capital
40.06
Listing of the Equity Shares on the Stock Exchanges